ACHILLION PHARMACEUTICALS INC 4
4 · ACHILLION PHARMACEUTICALS INC · Filed Dec 30, 2015
Insider Transaction Report
Form 4
Apelian David
EVP and Chief Medical Officer
Transactions
- Sale
Common Stock
2015-12-30$10.50/sh−10,000$105,000→ 0 total - Exercise/Conversion
Common Stock
2015-12-30$3.02/sh+10,000$30,200→ 10,000 total - Exercise/Conversion
Employee Stock Option
2015-12-30−10,000→ 290,000 totalExercise: $3.02Exp: 2023-12-17→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]This option was granted on December 17, 2013 and vests over a four year period with 25% of the shares vesting on the first anniversary of the date of grant and an additional 6.25% vesting at the end of each three month-month period thereafter.